Vaccine Type: Protein Subunit
This vaccine may also be referred to as Recombinant COVID-19 Vaccine (CHO cell, NVSI-06-08)
This vaccine is approved.
About Trial Phases
United Arab Emirates
Total Enrollment: 1,848
Total Enrollment: 3,580
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form